CAMP4 Therapeutics Corporation (CAMP) vs Cue Biopharma, Inc. (CUE)

CAMP4 Therapeutics Corporation and Cue Biopharma, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Cue Biopharma, Inc. are of similar size ($241.0M and $238.6M). Cue Biopharma, Inc. has the higher net margin (−435.8% vs −2,543.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, CAMP4 Therapeutics Corporation leads on 6 and Cue Biopharma, Inc. on 6.

Valuation

Metric CAMP CUE Biotechnology median
P/E n/m n/m 7.88
P/S 53.86 5.29 11.47
P/B n/m 86.22 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 33.21 4.87 10.73
Earnings yield (59.18%) (86.03%) (28.84%)
Free cash flow yield (12.63%) (25.17%) (23.03%)

Profitability

Metric CAMP CUE Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (1,254.22%) (262.03%) 0.00%
Net margin (2,543.74%) (435.83%) 0.00%
Free cash flow margin (680.36%) (133.13%) 0.00%
Return on equity (545.85%) (1,603.48%) (57.72%)
Return on assets (148.23%) (459.60%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CAMP CUE Biotechnology median
Revenue growth (TTM) — 354.37% 5.64%
EPS growth (last fiscal year) 76.00% 61.11% —
Revenue growth, 5-year CAGR — 54.16% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CAMP CUE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.70 1.25 4.73
Net debt to EBITDA 2.18 1.10 0.96

Dividend

Metric CAMP CUE Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric CAMP CUE Biotechnology median
Market cap 240.97m 238.64m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack